Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat
- PMID: 8546906
- PMCID: PMC2074320
- DOI: 10.1038/bjc.1996.35
Flow cytometric analysis of neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat
Abstract
Alterations in DNA ploidy accompany hepatocellular carcinoma (HCC). However, changes in DNA content are also seen in regenerating liver and with increasing age. Thus, to investigate the role of DNA ploidy changes in development of HCC, flow cytometric DNA content determinations were done in a rat model system of peroxisome proliferator-induced HCC. Paraffin blocks of liver isolated from 18 Fisher 344 male rats fed ciprofibrate for 20 weeks (4), 40 weeks (4) or 20 months (10) were examined. Livers from age-matched control rats were also examined. From the 20 month ciprofibrate group, nine neoplastic nodules (NNs), 27 HCCs and four non-tumorous surrounding tissue controls (NTCs) were examined. Significant DNA tetraploid populations were seen in both the NNs and NTCs. A significant increase in the percentage of DNA diploid cells was observed in the NN samples. No significant difference in the percentage S-phase cells was seen. Emergence of cell populations with new DNA ploidy classes (8c or DNA aneuploid) as compared with NTCs was only seen in HCCs (7 of 27), and five of these seven were DNA aneuploid, as distinct from DNA tetraploid, populations. A total of 16 of 24 HCC samples that were adequate for cell cycle analysis had average percent S-phase greater than the mean of the NTCs plus three standard deviations. Although a direct role cannot be inferred, these results support the hypothesis that increases in the fraction of diploid cells is an important early event in the development of rat HCC and that further alterations in DNA ploidy and increased proliferative fraction accompany the development of HCC.
Similar articles
-
Peroxisome proliferation in neoplastic nodules and hepatocellular carcinomas induced by ciprofibrate in the rat.Exp Pathol. 1991;41(1):44-9. doi: 10.1016/s0232-1513(11)80045-9. Exp Pathol. 1991. PMID: 2022255
-
Induction of peroxisome proliferation and hepatic tumours in C57BL/6N mice by ciprofibrate, a hypolipidaemic compound.Br J Cancer. 1988 Jul;58(1):46-51. doi: 10.1038/bjc.1988.159. Br J Cancer. 1988. PMID: 2901849 Free PMC article.
-
Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats.Cancer Lett. 1986 Jul;32(1):33-9. doi: 10.1016/0304-3835(86)90036-4. Cancer Lett. 1986. PMID: 3742486
-
Absence of gamma-glutamyltranspeptidase activity in lung metastasis in rats with hepatocellular carcinomas induced by ciprofibrate, a peroxisome proliferator.Cancer Lett. 1987 Dec;38(1-2):65-71. doi: 10.1016/0304-3835(87)90201-1. Cancer Lett. 1987. PMID: 2891433
-
Genetic instability occurs sooner than expected: promotion, progression and clonality during hepatocarcinogenesis in the rat.Basic Life Sci. 1991;57:263-77. doi: 10.1007/978-1-4684-5994-4_23. Basic Life Sci. 1991. PMID: 1667572 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources